AKT1 and cancer: In this study, using a combination of TCM network pharmacology and bioinformatics, we found that the potential core targets of HSG against PLC were mainly related to viral carcinogenesis, pathways in cancer, cell cycle, PI3K-Akt and MAPK signaling pathways.